2021 Journal Article Synthesis of human amyloid restricted to liver results in an Alzheimer disease–like neurodegenerative phenotypeLam, Virginie, Takechi, Ryusuke, Hackett, Mark J., Francis, Roslyn, Bynevelt, Michael, Celliers, Liesl M., Nesbit, Michael, Mamsa, Somayra, Arfuso, Frank, Das, Sukanya, Koentgen, Frank, Hagan, Maree, Codd, Lincoln, Richardson, Kirsty, O’Mara, Brenton, Scharli, Rainer K., Morandeau, Laurence, Gauntlett, Jonathan, Leatherday, Christopher, Boucek, Jan and Mamo, John C.L. (2021). Synthesis of human amyloid restricted to liver results in an Alzheimer disease–like neurodegenerative phenotype. PLoS Biology, 19 (9) e3001358, 1-26. doi: 10.1371/journal.pbio.3001358 |
2021 Journal Article Impact of COVID-19 pandemic on cardiovascular testing in Asia: the IAEA INCAPS-COVID StudyKudo, Takashi, Lahey, Ryan, Hirschfeld, Cole B., Williams, Michelle C., Lu, Bin, Alasnag, Mirvat, Bhatia, Mona, Henry Bom, Hee-Seung, Dautov, Tairkhan, Fazel, Reza, Karthikeyan, Ganesan, Keng, Felix Y.J., Rubinshtein, Ronen, Better, Nathan, Cerci, Rodrigo Julio, Dorbala, Sharmila, Raggi, Paolo, Shaw, Leslee J., Villines, Todd C., Vitola, João V., Choi, Andrew D., Malkovskiy, Eli, Goebel, Benjamin, Cohen, Yosef A., Randazzo, Michael, Pascual, Thomas N.B., Pynda, Yaroslav, Dondi, Maurizio, Paez, Diana ... Nguyen, Xuan Canh (2021). Impact of COVID-19 pandemic on cardiovascular testing in Asia: the IAEA INCAPS-COVID Study. JACC: Asia, 1 (2), 187-199. doi: 10.1016/j.jacasi.2021.06.002 |
2021 Journal Article Repeatability of image features extracted from FET PET in application to post-surgical glioblastoma assessmentBarry, Nathaniel, Rowshanfarzad, Pejman, Francis, Roslyn J., Nowak, Anna K. and Ebert, Martin A. (2021). Repeatability of image features extracted from FET PET in application to post-surgical glioblastoma assessment. Physical and Engineering Sciences in Medicine, 44 (4), 1131-1140. doi: 10.1007/s13246-021-01049-4 |
2021 Journal Article The australasian radiopharmaceutical trials network: Clinical trials, evidence, and opportunityFrancis, Roslyn J., Bailey, Dale L., Hofman, Michael S. and Scott, Andrew M. (2021). The australasian radiopharmaceutical trials network: Clinical trials, evidence, and opportunity. Journal of Nuclear Medicine, 62 (6), 755-756. doi: 10.2967/jnumed.120.258152 |
2021 Journal Article Repeatability of quantitative 18F-FET PET in glioblastomaFerjančič, Peter, Ebert, Martin A., Francis, Roslyn, Nowak, Anna K. and Jeraj, Robert (2021). Repeatability of quantitative 18F-FET PET in glioblastoma. Biomedical Physics and Engineering Express, 7 (3) 035020, 1-10. doi: 10.1088/2057-1976/abfae9 |
2021 Journal Article UpFrontPSMA: a randomized phase 2 study of sequential 177Lu-PSMA-617 and docetaxel vs docetaxel in metastatic hormone-naive prostate cancer (clinical trial protocol)Dhiantravan, Nattakorn, Emmett, Louise, Joshua, Anthony M., Pattison, David A., Francis, Roslyn J., Williams, Scott, Sandhu, Shahneen, Davis, Ian D., Vela, Ian, Neha, Nitika, Bressel, Mathias, Murphy, Declan G., Hofman, Michael S. and Azad, Arun A. (2021). UpFrontPSMA: a randomized phase 2 study of sequential 177Lu-PSMA-617 and docetaxel vs docetaxel in metastatic hormone-naive prostate cancer (clinical trial protocol). BJU International, 128 (3) bju.15384, 331-342. doi: 10.1111/bju.15384 |
2021 Journal Article Is Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Imaging Cost-effective in Prostate Cancer: An Analysis Informed by the proPSMA Trialde Feria Cardet, Rafael E., Hofman, Michael S., Segard, Tatiana, Yim, Jackie, Williams, Scott, Francis, Roslyn J., Frydenberg, Mark, Lawrentschuk, Nathan, Murphy, Declan G. and De Abreu Lourenco, Richard (2021). Is Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Imaging Cost-effective in Prostate Cancer: An Analysis Informed by the proPSMA Trial. European Urology, 79 (3), 413-418. doi: 10.1016/j.eururo.2020.11.043 |
2021 Journal Article Coronary 18F-sodium fluoride PET detects high-risk plaque features on optical coherence tomography and CT-angiography in patients with acute coronary syndromeMajeed, Kamran, Bellinge, Jamie W., Butcher, Steele C., Alcock, Richard, Spiro, Jon, Playford, David, Hillis, Graham S., Newby, David E., Mori, Trevor A., Francis, Roslyn and Schultz, Carl J. (2021). Coronary 18F-sodium fluoride PET detects high-risk plaque features on optical coherence tomography and CT-angiography in patients with acute coronary syndrome. Atherosclerosis, 319, 142-148. doi: 10.1016/j.atherosclerosis.2020.12.010 |
2020 Journal Article Re: Prostate-Specific Membrane Antigen PET-CT in Patients with High-Risk Prostate Cancer before Curative-Intent Surgery or Radiotherapy (proPSMA): A Prospective, Randomised, Multicentre StudyHofman, M. S., Lawrentschuk, N., Francis, R. J., Tang, C., Vela, I., Thomas, P., Rutherford, N., Martin, J. M., Frydenberg, M., Shakher, R., Wong, L. M., Taubman, K., Lee, S. T., Hsiao, E., Roach, P., Nottage, M., Kirkwood, I., Hayne, D., Link, E., Marusic, P., Matera, A., Herschtal, A., Iravani, A., Hicks, R. J., Williams, S., Murphy, D. G. and Taneja, Samir S. (2020). Re: Prostate-Specific Membrane Antigen PET-CT in Patients with High-Risk Prostate Cancer before Curative-Intent Surgery or Radiotherapy (proPSMA): A Prospective, Randomised, Multicentre Study. Journal of Urology, 204 (4), 878-879. doi: 10.1097/JU.0000000000001220.01 |
2020 Journal Article 3-year freedom from progression following 68GaPSMA PET CT triaged management in men with biochemical recurrence post radical prostatectomy: results of a prospective multi-center trialEmmett, Louise, Tang, Reuben, Nandurkar, Rohan H., Hruby, George, Roach, Paul J., Watts, Jo Anne, Cusick, Thomas, Kneebone, Andrew, Ho, Bao, Chan, Lyn, van Leeuwen, Pim, Scheltema, Matthijs, Nguyen, Andrew, Yin, Charlotte, Scott, Andrew, Tang, Colin, McCarthy, Michael, Fullard, Karen, Roberts, Matthew, Francis, Roslyn and Stricker, Phillip (2020). 3-year freedom from progression following 68GaPSMA PET CT triaged management in men with biochemical recurrence post radical prostatectomy: results of a prospective multi-center trial. The Journal of Nuclear Medicine, 61 (6), 866-872. doi: 10.2967/jnumed.119.235028 |
2020 Journal Article Coronary artery 18F-NaF PET analysis with the use of an elastic motion correction softwareBellinge, Jamie W., Majeed, Kamran, Carr, Stuart S., Jones, Judson, Hong, Inki, Francis, Roslyn J. and Schultz, Carl J. (2020). Coronary artery 18F-NaF PET analysis with the use of an elastic motion correction software. Journal of Nuclear Cardiology, 27 (3), 952-961. doi: 10.1007/s12350-018-01587-7 |
2020 Journal Article Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre studyHofman, Michael S., Lawrentschuk, Nathan, Francis, Roslyn J., Tang, Colin, Vela, Ian, Thomas, Paul, Rutherford, Natalie, Martin, Jarad M., Frydenberg, Mark, Shakher, Ramdave, Wong, Lih-Ming, Taubman, Kim, Ting Lee, Sze, Hsiao, Edward, Roach, Paul, Nottage, Michelle, Kirkwood, Ian, Hayne, Dickon, Link, Emma, Marusic, Petra, Matera, Anetta, Herschtal, Alan, Iravani, Amir, Hicks, Rodney J., Williams, Scott and Murphy, Declan G. (2020). Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study. The Lancet, 395 (10231), 1208-1216. doi: 10.1016/S0140-6736(20)30314-7 |
2020 Journal Article Baseline and post-treatment 18F-fluorocholine PET/CT predicts outcomes in hepatocellular carcinoma following locoregional therapyWallace, Michael C., Sek, Kenny, Francis, Roslyn J., Samuelson, Shaun, Ferguson, John, Tibballs, Jonathan, Asad, Ali, Preen, David B., MacQuillan, Gerry, Garas, George, Adams, Leon A. and Jeffrey, Gary P. (2020). Baseline and post-treatment 18F-fluorocholine PET/CT predicts outcomes in hepatocellular carcinoma following locoregional therapy. Digestive Diseases and Sciences, 65 (2), 647-657. doi: 10.1007/s10620-019-05781-6 |
2019 Journal Article TheraP: a randomized phase 2 trial of 177Lu-PSMA-617 theranostic treatment vs cabazitaxel in progressive metastatic castration-resistant prostate cancer (Clinical Trial Protocol ANZUP 1603)Hofman, Michael S., Emmett, Louise, Violet, John, Y. Zhang, Alison, Lawrence, Nicola J., Stockler, Martin, Francis, Roslyn J., Iravani, Amir, Williams, Scott, Azad, Arun, Martin, Andrew, McJannett, Margaret and Davis, Ian D. (2019). TheraP: a randomized phase 2 trial of 177Lu-PSMA-617 theranostic treatment vs cabazitaxel in progressive metastatic castration-resistant prostate cancer (Clinical Trial Protocol ANZUP 1603). BJU International, 124 (S1), 5-13. doi: 10.1111/bju.14876 |
2019 Journal Article Imaging in pleural mesothelioma: A review of the 14th International Conference of the International Mesothelioma Interest GroupArmato, Samuel G., Francis, Roslyn J., Katz, Sharyn I., Ak, Guntulu, Opitz, Isabelle, Gudmundsson, Eyjolfur, Blyth, Kevin G. and Gupta, Ashish (2019). Imaging in pleural mesothelioma: A review of the 14th International Conference of the International Mesothelioma Interest Group. Lung Cancer, 130, 108-114. doi: 10.1016/j.lungcan.2018.11.033 |
2019 Journal Article Comparison between gallium-68 citrate positron emission tomography-computed tomography and gallium-67 citrate scintigraphy for infection imagingSegard, Tatiana, Morandeau, Laurence M. J. A., Dunne, Marina L., Robinson, James O., Murray, Ronan J., Geelhoed, Elizabeth A. and Francis, Roslyn J. (2019). Comparison between gallium-68 citrate positron emission tomography-computed tomography and gallium-67 citrate scintigraphy for infection imaging. Internal Medicine Journal, 49 (8), 1016-1022. doi: 10.1111/imj.14231 |
2018 Journal Article In search of the vulnerable patient or the vulnerable plaque: 18F-sodium fluoride positron emission tomography for cardiovascular risk stratificationBellinge, Jamie W., Francis, Roslyn J., Majeed, Kamran, Watts, Gerald F. and Schultz, Carl J. (2018). In search of the vulnerable patient or the vulnerable plaque: 18F-sodium fluoride positron emission tomography for cardiovascular risk stratification. Journal of Nuclear Cardiology, 25 (5), 1774-1783. doi: 10.1007/s12350-018-1360-2 |
2018 Journal Article 68Ga-somatostatin analogue PET-CT: Analysis of costs and benefits in a public hospital settingSegard, Tatiana, Morandeau, Laurence M. J. A., Geelhoed, Elizabeth A and Francis, Roslyn J (2018). 68Ga-somatostatin analogue PET-CT: Analysis of costs and benefits in a public hospital setting. Journal of Medical Imaging and Radiation Oncology, 62 (1), 57-63. doi: 10.1111/1754-9485.12638 |
2018 Journal Article The impact of 68 Ga-PSMA PET/CT on management intent in prostate cancer: Results of an australian prospective multicenter studyRoach, Paul J., Francis, Roslyn, Emmett, Louise, Hsiao, Edward, Kneebone, Andrew, Hruby, George, Eade, Thomas, Nguyen, Quoc A., Thompson, Benjamin D., Cusick, Thomas, McCarthy, Michael, Tang, Colin, Ho, Bao, Stricker, Philip D. and Scott, Andrew M. (2018). The impact of 68 Ga-PSMA PET/CT on management intent in prostate cancer: Results of an australian prospective multicenter study . Journal of Nuclear Medicine, 59 (1), 82-88. doi: 10.2967/jnumed.117.197160 |
2017 Journal Article Is FCH PET able to identify foci of infection superiorly to FDG PET?Hardy, Liesel Elisabeth, Hessamodini, Hannah, Wallace, Michael and Francis, Roslyn (2017). Is FCH PET able to identify foci of infection superiorly to FDG PET?. BMJ Case Reports, 2017 bcr-2017-219944, bcr-2017. doi: 10.1136/bcr-2017-219944 |